Stayble Therapeutics AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Andreas Gerward, was filed 06 Dec 2024.
Stayble Therapeutics AB: what insiders have been doing
Stayble Therapeutics AB is a listed company. Its insiders report their share dealings to Finansinspektionen. Stayble Therapeutics AB has had no insider filing for more than a year; the last one goes back to 6 December 2024.
The full history, which starts in 2020, counts 19 purchases against 2 sales.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 40,000 shares@ SEK 0.4713.4% of flowAktieISIN SE0013513652FI:csv-ee078ff813c5631a5441Canonical exit: 6 Mar 2025 (T+90)
- 32,000 shares@ SEK 0.3210.4% of flowAktieISIN SE0013513652FI:csv-bec7d04ba1f19f06af92Canonical exit: 10 Sept 2024 (T+90)
- 160,000 shares@ SEK 0.3035.1% of flowAktieISIN SE0013513652FI:csv-02ade8dda4e159d2f0b5Canonical exit: 10 Sept 2024 (T+90)
- 50,000 shares@ SEK 0.27814.1% of flowAktieISIN SE0013513652FI:csv-0ee06b8ea4407fa9a9e8Canonical exit: 7 Mar 2024 (T+90)
- 5,000 shares@ SEK 1.929.5% of flowAktieISIN SE0013513652FI:csv-08ed8dc4d5245cfdbae6Canonical exit: 12 Oct 2023 (T+90)
- 5,000 shares@ SEK 21.9946AktieISIN SE0013513652FI:csv-3e40ab153d8f6d316d35Canonical exit: 12 Oct 2023 (T+90)
- 30,000 shares@ SEK 1.2838.0% of flowAktieISIN SE0013513652FI:csv-fa02a9d396ebf70c3e30Canonical exit: 22 Aug 2023 (T+90)
- 6,660 shares@ SEK 1.7819.3% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-6af7ee43d2e70e5c42df
- 6,660 shares@ SEK 1.7819.1% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-ffccd2a58b17a4815b0b
- 23,000 shares@ SEK 1.78100.0% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-6d35facc8695abc558dcCanonical exit: 16 Jul 2023 (T+90)
- 44,940 shares@ SEK 1.78100.0% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-3d3c65b39ee879d8df71Canonical exit: 13 Jul 2023 (T+90)
- 21,420 shares@ SEK 1.7861.6% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-21be503e54248e640839
- 15,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-89fbe70443145e06a654
- 40,000 shares@ SEK 1.7851.4% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-b014ac7f2290b20f22a9
- 28,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-fecd16564f29b9e882b8
- 250,599 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-bf8dd7d3ab3a59aad247
- 8,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-6b35c146bf06c19ac8c2
- 3,000 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-a3a5252eb93aa7cdbdb2
- 11,420 shares@ SEK 1.7820.4% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-d40602e3759420b06e67Canonical exit: 11 Jul 2023 (T+90)
- 4,280 shares@ SEK 1.787.6% of flowBTA (betald tecknad aktie)ISIN SE0019912874FI:csv-8eabebea7d339f938d53Canonical exit: 11 Jul 2023 (T+90)
- 90,000 sharesTeckningsrätt/UniträttISIN SE0019912866FI:csv-34c5ea5b35ccb0203365
- 190,000 shares0Teckningsrätt/UniträttFI:csv-99f7d9681563d9a28410
- 81,401 shares0Teckningsrätt/UniträttISIN SE0019912866FI:csv-6288494d2dbbdc02f691
- 30,000 shares0AktieISIN SE0013513652FI:csv-4a9cedb78c3fbc59ae14
- 15,000 shares@ SEK 4.89AktieISIN SE0013513652FI:csv-d3654bc9db0e699c91d6Canonical exit: 29 Nov 2022 (T+90)
25 of 40 declarations
About Stayble Therapeutics AB
Stayble Therapeutics AB is a biopharmaceutical company focused on developing treatments for chronic pain. It is listed on the XSTO exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations